Applications

1717 – Extravascular implantable cardioverter defibrillator therapy for patients at risk of ventricular arrhythmia

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

Application details

Reason for application

New MBS item.

Service or technology in this application

Extravascular implantable cardioverter defibrillaton (EV-ICD) is an alternative option for patients where traditional transvenous ICD is not ideal or feasible. For single-chamber EV-ICD, a battery-powered pulse generator is implanted in a pouch under the skin near the serratus muscle, found on the ribs on the left side. The electrode runs from the pulse generator to the anterior mediastinum, the front part of the chest between the lungs. If an abnormal heart rhythm is detected, the device will deliver an electric current to the heart, known as defibrillation, to restore a normal heartbeat.

Type: Therapeutic technology

Medical condition this application addresses

Ventricular arrhythmias are abnormal heartbeats that originate from the lower heart chambers, known as ventricles. These types of arrhythmias cause the heart to beat too fast, which prevents oxygen-rich blood from circulating to the brain and body and may result in sudden cardiac death. The most common types of ventricular arrythmias are ventricular tachycardia and ventricular fibrillation.

Consultation survey and deadlines

Meetings to consider this application

  • PASC meeting: 11–12 August 2022
  • ESC meeting: To be confirmed
  • MSAC meeting: To be confirmed